Mark Rosenbach

Statistics

Publications

Citations

3.9K

H-Index

Active since

1997

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Mark Rosenbach is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, drug discovery, and medicinal chemistry.

Publications per year

1997–2019

Publications

Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists

Suzanne Mandala, Richard Hajdu, James D. Bergstrom et al. · Science · 2002 · 1.7K citations

Life Sciences, Immunology, Pharmacology +17

Mice Deficient in Sphingosine Kinase 1 Are Rendered Lymphopenic by FTY720

María L. Allende, Teiji Sasaki, Hiromichi Kawai et al. · Journal of Biological Chemistry · 2004 · 445 citations · Full text

Life Sciences, Biochemistry, Cell Biology +15

Immune Cell Regulation and Cardiovascular Effects of Sphingosine 1-Phosphate Receptor Agonists in Rodents Are Mediated via Distinct Receptor Subtypes

M J Forrest, S.-Y. Sun, Richard Hajdu et al. · Journal of Pharmacology and Experimental Therapeutics · 2004 · 334 citations

Medicine, Pharmacology, Physiology +17

Discovery of Novel Antifungal (1,3)-β- <scp>d</scp> -Glucan Synthase Inhibitors

Janet C. Onishi, M. Meinz, John R. Thompson et al. · Antimicrobial Agents and Chemotherapy · 2000 · 319 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Khafrefungin, a Novel Inhibitor of Sphingolipid Synthesis

Suzanne Mandala, Rosemary Thornton, Mark Rosenbach et al. · Journal of Biological Chemistry · 1997 · 137 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +14

1–5 of 28